What Aver Generics say about themselves
“Family run wholesale pharmaceutical company, supplying drugs and medicines at competitive prices across the UK”
Aver Generics Limited
- Incorporated
- 25 January 2013 (13 years)
- Previously known as
- RX Generics Limited (until 20 February 2013)This list may be incomplete. See all names on Companies House
- Industry
- Wholesale of pharmaceutical goods (46460) Business and domestic software development (62012)
- Directors
- Craig Mcdowall
- Owned by
- Craig Howard McdowallIan McdowallAlison Mcdowall
- Accounts type
- Group
- Region
- Scotland
- Address
- 20 Singer RoadEast KilbrideGlasgowG75 0XS
Website & contact details
- Website
Filing status
- Accounts due
- 30 November 2026
- Last accounts
- 28 February 2025
- Conf. stmt due
- 8 May 2027
- Last conf. stmt
- 24 April 2026
Charges
- Total
- 2
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 0
Officers 1 active
Officer details are public data from the Companies House register.
Mcdowall, Craig
Director · Appointed 24 November 2020
Scottish
Born August 1990 (36)
Officer history (1 former)
14 October 2024
24 November 2020
Appointed Mcdowall, Craig as Director
25 January 2013
Ownership 3 active
People and entities with significant control, from the Companies House PSC register
Craig Howard Mcdowall
Individual · Notified 14 October 2025
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born August 1990 (36)
Ian Mcdowall
Individual · Notified 14 October 2025
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born December 1993 (32)
Alison Mcdowall
Individual · Notified 14 October 2025
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born December 1991 (34)
Holdings 2
Companies where Aver Generics Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Former controllers (1)
14 October 2025
Financials
Figures from 2024 accounts. Newer accounts, made up to 28 February 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £2,355,999
- Cash
- £254,279
- Profit
- £1,205,849
- Employees
- 84
- Debt Ratio
- 75%
- Current Ratio
- 1.3x
- Return on Equity
- 51%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fixed Assets | £1,911,415 | £471,802 | £33,078 | £42,867 | £55,996 |
| Current Assets | £7,367,553 | £6,384,042 | £3,843,951 | £4,423,373 | £4,116,018 |
| Debtors | £5,451,197 | £4,116,007 | £2,631,542 | £3,261,687 | £2,839,586 |
| Cash | £254,279 | £47,496 | £82,107 | £20,690 | £78,176 |
| Creditors (< 1 year) | £5,703,739 | £4,909,809 | £3,115,963 | £3,892,181 | £3,696,384 |
| Creditors (> 1 year) | £1,064,759 | £57,559 | |||
| Net Current Assets | £1,663,814 | £1,474,233 | £727,988 | £531,192 | £419,634 |
| Net Assets | £2,355,999 | £1,739,046 | £754,376 | £565,509 | £467,524 |
| Shareholder Funds | £2,355,999 | £1,739,046 | £754,376 | £565,509 | £467,524 |
| Turnover | £21,113,199 | ||||
| Cost of Sales | £16,204,925 | ||||
| Gross Profit | £4,908,274 | ||||
| Admin Expenses | £2,986,275 | ||||
| Staff Costs | £1,933,828 | ||||
| Operating Profit | £1,801,770 | ||||
| Profit Before Tax | £1,798,657 | ||||
| Tax | £381,849 | ||||
| Profit for Period | £1,205,849 | £1,416,808 | £515,053 | £944,985 | £613,773 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 23 June 2026 | Confirmation statement with updates | 24 April 2026 | ||
| 2 December 2025 | Purchase of own shares | |||
| 2 December 2025 | Purchase of own shares | |||
| 28 November 2025 | Group of companies' accounts | 28 February 2025 | ||
| 23 October 2025 | Cancellation of shares |
Some other companies at this address
Other companies in this industry
Kelso
Welwyn Garden City
Kent
London
Addlestone
Reading
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →